Tag: theranostics industry research

  • Global Theranostics Market Report 2024: Size, Drivers, And Top Segments

    Global Theranostics Market Report 2024: Size, Drivers, And Top Segments

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    How is the Theranostics Market Expected to Expand from 2024 to 2033?

    There has been a significant expansion in the size of the theranostics market recently. Its growth trajectory indicates an escalation from $98.91 billion in 2023 to $110.41 billion in 2024, accruing a compound annual growth rate (CAGR) of 11.6%. The historic growth rate is ascribed to improvements in molecular imaging, transition towards value-based healthcare and integration within oncology.

    In the forthcoming years, the theranostics market is set for an accelerated expansion, expecting to reach a valuation of $164.38 billion by 2028. This represents a compound annual growth rate (CAGR) of 10.5%. The predicted growth over this period can be linked to an increase in precision medicine initiatives, wider applications beyond oncology, growing aging population and chronic diseases, advancements in biomarker discovery, coupled with government backing and funding. Noteworthy trends during this forecast period include regulatory assistance, the emergence of companion diagnostics, heightened emphasis on cancer theranostics, amplified patient engagement and awareness, along with technological convergence.

    Claim Your Free Sample of the Global Theranostics Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10823&type=smp

    What Influences Are Propelling the theranostics Market Forward?

    The escalating incidence of cancer is anticipated to drive the expansion of the theranostics market ahead. Cancer is characterized by unmanaged cell proliferation that affects several organs and leads to significant morbidity and mortality globally. Theranostics – a blend of therapeutics and diagnostics – holds enormous potential for managing cancer and chronic diseases. This technique facilitates personalized and targeted treatment methodologies by fusing diagnostic and therapeutic capabilities, thus paving the way for innovations in the healthcare sector. Consequently, the surge in the number of cancer patients will fuel the growth of the theranostics market. For instance, data from the National Cancer Institute (NCI) – a US government agency part of the National Institutes of Health (NIH) dedicated to cancer research, prevention, and treatment – shows that in January 2022, nearly 5.4% or 18.1 million individuals of the US population were cancer survivors. Additionally, in 2022, 623,405 people were living with metastatic breast, prostate, lung, colorectal, or bladder cancer or metastatic melanoma, a figure predicted to increase to 693,452 by 2025. Hence, the increasing prevalence of cancer significantly propels the growth of the theranostics market.

    What Key Segments Exist Within the Theranostics Market?

    1) By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases

    2) By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies

    3) By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

    What Trends Are Coming to the Forefront in the Theranostics Market?

    The escalating convergence of imaging and therapeutic technologies is an emergent trend in the theranostics market. Many key players in this market are merging a spectrum of imaging and therapeutic technologies to offer highly accurate and individualized treatments for a diverse array of medical issues. They aim to improve patient care and uphold their market position. For example, in March 2021, GE HealthCare Technologies Inc, an American medical technology firm, introduced a novel SPECT/CT technology, StarGuide, designed to aid clinicians in their research. This state-of-the-art system incorporates the newest Cadmium Zinc Telluride (CZT) technology, enabling healthcare professionals to acquire profound insights into patient conditions and enhance patient outcomes in various medical fields. With StarGuide’s digital concentrated detectors and 360-degree imaging, it is anticipated to reinforce precision health and strengthen theranostic abilities in the realm of nuclear medicine.

    Order Now for Fast Delivery of Your Theranostics Market Report!

    https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

    What Regions Are Leading the Charge in the Theranostics Market?

    North America was the largest region in the global theranostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the theranostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Theranostics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the theranostics market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Theranostics Market Include

    1. Theranostics Market Executive Summary

    2. Theranostics Market Segments

    3. Theranostics Market Size And Template Market Growth Rate

    4. Key Theranostics Market Trends

    5. Major Theranostics Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Theranostics Market

    26. Top Theranostics Companies

    27. Theranostics Market Opportunities And Strategies

    28. Theranostics Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Autonomous Aircraft Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/autonomous-aircraft-global-market-report

    Autonomous Military Aircraft Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/autonomous-military-aircraft-global-market-report

    Vegan Food Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/vegan-food-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • How Is The Theranostics Market Expected To Grow Through 2024-2033

    How Is The Theranostics Market Expected To Grow Through 2024-2033

    The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2024 and forecasted to 2033

    According to The Business Research Company’s Theranostics Global Market Report 2024, the theranostics market is expected to show promising growth in the forecast period.

    Introduction: A Thriving Market
    The theranostics market has witnessed a remarkable surge in recent years, driven by a confluence of factors including technological advancements, shifting healthcare paradigms, and increasing prevalence of chronic diseases. The market size is projected to expand from $98.91 billion in 2023 to $110.41 billion in 2024, with a compound annual growth rate (CAGR) of 11.6%.

    A Growing Landscape: Historic Insights

    • Advancements in molecular imaging
    • Shift towards value-based healthcare
    • Integration in oncology

    Future Prospects: Forecasted Growth
    The trajectory of the theranostics market continues to ascend, with forecasts indicating a robust growth pattern. By 2028, the market is estimated to reach $164.38 billion, boasting a CAGR of 10.5%.

    • Rise in precision medicine initiatives
    • Expanding applications beyond oncology
    • Population aging and chronic diseases
    • Advancements in biomarker discovery
    • Government support and funding

    Emerging Trends: What Lies Ahead
    In the forecast period, several trends are poised to reshape the landscape of theranostics:

    • Regulatory support
    • Rise of companion diagnostics
    • Increased focus on cancer theranostics
    • Patient engagement and awareness
    • Technological convergence

    Rising Cancer Prevalence Fuels Growth In The Theranostics Market
    The escalating prevalence of cancer serves as a significant catalyst for the expansion of the theranostics market. With cancer posing a formidable global health challenge, the integration of therapeutics and diagnostics offers a beacon of hope in the realm of personalized medicine.

    • Impact of cancer on global morbidity and mortality
    • Theranostics as a personalized and targeted treatment approach
    • Insights from the National Cancer Institute (NCI)

    View More On The Theranostics Market Report 2024 – https://www.thebusinessresearchcompany.com/report/theranostics-global-market-report

    Technological Integration: A Paradigm Shift
    The integration of imaging and treatment technologies stands as a pivotal trend in the theranostics domain. Major players in the market are leveraging advanced technologies to augment diagnostic precision and therapeutic efficacy.

    • Integration of multiple imaging and treatment technologies
    • Advancements in nuclear medicine, exemplified by GE HealthCare Technologies Inc.
    • Radiopharm Theranostics’ strategic acquisition to bolster prostate cancer treatment

    Segmentation Insights: Understanding Market Dynamics
    The theranostics market encompasses diverse segments, reflecting the multifaceted nature of medical diagnostics and treatment modalities.

    1. By Disease Type: Neurological Disorders, Cardiovascular Diseases, Immunological Disorders, Oncology Diseases, Other Diseases
    2. By Technology: Polymerase Chain Reaction, Immunohistochemistry, In-Situ Hybridization, Sequencing, Other Technologies
    3. By End User: Hospitals And Clinics, Diagnostic Laboratories, Other End Users

    Regional Dynamics: The Global Canvas

    • North America emerges as the largest region in the global theranostics market
    • Asia-Pacific poised for rapid growth in the forecast period

    In conclusion, the theranostics market stands at the nexus of innovation and transformation within the healthcare landscape. As advancements in technology continue to unfold and awareness about personalized medicine proliferates, the journey of theranostics promises to redefine the contours of medical diagnosis and treatment, offering renewed hope to patients and clinicians alike.

    Request A Sample Of The Global Theranostics Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=10823&type=smp